Thirteen monoclonal antibodies (MAbs) were prepared against human parainfluenza virus type 2 (PIV2). These MAbs reacted with the haemagglutininneuraminidase glycoprotein with an Mr of 84K. The MAbs defined one antigenic site which could be divided.into five epitopes. A correlation between haemagglutination inhibition (HI) and neutralization activity could be seen although one MAb, which recognized a distinct epitope, showed neutralization and no HI activity to PIV2.
Parainfluenza virus type 2 (PIV2) is a major human respiratory pathogen. It causes mild upper respiratory tract disease in adults but can produce more severe symptoms in children, in whom interstitial pneumonia and croup occasionally occur (Glezen et al., 1982) . PIV2 is a member of the Paramyxoviridae (Kingsbury et al., 1978) and has been demonstrated to possess six structural proteins, the large, haemagglutinin-neuraminidase (HN), fusion (F), phospho-, nucleocapsid (NP) and matrix proteins (Cowley & Barry, 1983 ; Goswami & Russell, 1982) . The two envelope surface glycoproteins HN and F are, by analogy to other paramyxoviruses, believed to be responsible for attachment of virions to cells and for fusion of viral and cellular membranes (Choppin & Scheid, 1980) . It has been demonstrated that the immune response towards these two surface glycoproteins of paramyxoviruses provides protection against reinfection, although it has been suggested that, with PIV2, re-infection frequently occurs (Glezen et al., 1982) . Monoclonal antibodies (MAbs) have been widely used for structural analysis of viral proteins for identification of epitopes and of antigenic relationships between different viruses. For example, several MAbs raised against parainfluenza virus type 3 (PIV3) and Sendal virus cross-react with the heterologous virus thereby demonstrating their structural relationship (()rvell et al., 1986) ; also one of two MAbs which were raised against the HN protein of simian virus 5 (SV5) has been shown to cross-react with the HN protein of PIV2 (Goswami & Russell, 1983) . Further, MAbs have been used to analyse intratypic variation between viral strains (Rydbeck et al., 1986a, b; van Wyke Coelingh et al., 1985) . MAbs to PIV2 have not previously been described and in this study a series of MAbs were prepared against the HN glycoprotein of PIV2. These antibodies were used for analysis of the immunogenic epitopes of the protein and to search for possible cross-reactions with other paramyxoviruses. Epitopes and antigenic sites are defined in this paper according to Yewdell & Gerhard (1981) . The formation of a complex between antigen (Ag) and antibody has been described in detail (Hogle et al., 1985) ; however, the limited structural adaptation of either the Ag or the Fab fragment when binding to each other (Colman et al., 1987) may suggest that even though there is a very distinct complementary contact area between Ag and antibody (Amit et al., 1986) an antibody is able to recognize more than one epitope (Huber & Bennett, 1987 continuous; it is common for two adjacent surface loops of a protein to form one epitope (Atassi, 1978) .
The PIV2 Greer strain of the American Tissue Culture Collection (ATCC), PIV3 (ATCC strain C 243), the SBL-1 strain of mumps virus (Rydbeck et al., 1986a) and the Colindale SV5 strain (Goswami & Russell, 1982) were kindly provided by Dr R. Randall and Professor W. C. Russell, University of St Andrews, U.K. ; the Montana strain of Newcastle disease virus (NDV) (Orvell, 1976) , the LEC strain of measles virus (Sheshberadaran et al., 1983) and the Convac vaccine (Dumex) strain of canine distemper virus (CDV) were grown in Vero cells maintained in Eagle's minimal essential medium (Flow Laboratories) containing 3 ~ foetal calf serum. The Z strain of Sendal virus (murine parainfluenza virus type 1) (Orvell & Grandien, 1982) was grown in embryonated eggs. All virus strains had been subjected to repeated passage in this laboratory. Extracellular virus material was pelleted from allantoic fluid or cell culture medium by centrifugation at 13000 r.p.m, for 90 min in a Sorvall high speed centrifuge using a GSA rotor. was carried out as previously described (K6hler & Milstein, 1975; Orvell & Grandien, 1982) . Radiolabelling of Ag, purification, radioimmune precipitation assay (RIPA) and gel analysis were performed as previously described (Rydbeck et al., 1986b) . The haemagglutination inhibition (HI) test was performed with human group O blood cells at 4 °C using Tween 80-and ether-treated viral antigen (Norrby, 1962) . The neutralizing capacity of the MAbs was tested with a plaque reduction assay (NT) (Rydbeck et al., 1986b) . The endpoint titre was defined as the reciprocal of the highest dilution giving 80~ reduction of plaques. ELISA was used for screening of hybridoma cell clones, for determination of antibody activity, antibody class and subclass and also for determination of epitope specificity of the MAbs in competition experiments (Orvell & Grandien, 1982; Orvell, 1984; Wilson & Nakane, 1978) . These tests were performed on microtitre plates coated with 10 p.g purified virions per ml (Orvell, 1984 ). An immunofluorescence (IF) test was performed on virus-infected Vero cells grown on microscope slides. The cells were fixed in cold acetone ( -20 °C) when cytopathic effects were pronounced. Staining of the slides was carried out as previously described (L6ve et al., 1986 ). Thirteen hybridoma cell clones which were secreting PIV2-specific antibodies against purified virus material were identified by ELISA. Titres and subclasses of the MAbs in ascites after passage in BALB/c mice are shown in Tables 1 and 2 . In the RIPA, ascites containing antibodies produced by the 13 hybridomas precipitated an 84K protein which was considered to be the H N glycoprotein (Fig. 1) . The specificity of this 84K protein was further confirmed by HI
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and NT activity of the monoclonal antibodies (Table 1) . MAbs possessing high neutralizing capacity also had high HI activity with the exception of MAB 2568 which had no HI activity but was highly neutralizing. Ascites material from the 13 hybridomas gave a specific granular cytoplasmic immunofluorescence staining of PIV2-infected Vero cells. The results of the competition ELISA using the MAbs are summarized in Table 2 . These demonstrate that the MAbs reacted with one major antigenic site on the HN molecule. This antigenic site can be subdivided into five overlapping epitopes. The epitopes can be further divided into three groups, one represented by MAbs 1393, 1399 and 1401, another by MAbs 1403, 1349, 1381, 1391 and 1373 and a third by MAbs 1405, 1351 and 1568; two additional epitopes were defined by MAbs 1404 and 2568 (Table 2 ). The MAbs against PIV2 did not react with the following viruses of the Paramyxoviridae in the IF test or ELISA: Sendai virus, PIV3, SV5, mumps virus, NDV, measles virus or CDV. However, MAb 1351 had a low HI titre of 32 with SV5.
This study confirms that the 72K to 84K protein described by other workers (Cowley & Barry, 1983; Goswami & Russell, 1983; Ito et al., 1987b ) is the HN protein. A band of 165K was also precipitated by the MAbs (Fig. 1) ; this was probably a dimeric form of the HN protein, as it was recently reported that the HN protein of PIV2 exists as a disulphide-linked dimer in infected Vero cells (Ito et al., 1987b) .
One major antigenic site on the HN protein of PiV2 was revealed. The site was composed of five epitopes, one of which reacted with five MAbs, two of which reacted with three MAbs and two of which reacted with only one MAb each. This is similar to that of the HN protein of PIV3 which consists of one major and three lesser antigenic sites, the latter being represented by only one MAb each and the major site containing at least five variably overlapping epitope groups. (Coelingh et al., 1986; Rydbeck et al., 1986 Rydbeck et al., b, 1987 van Wyke Coelingh et al., 1985 ; Yewdell & Gerhard, 1981) . MAb 1351 was similar in competition experiments to M Abs 1405 and 1568. The presence of HI activity to SV5 showed that this antibody was distinct in its ability to bind to the HN protein.
It should be noted that all antibodies against the antigenic site have both neutralizing and HI activity, except antibody 2568 which possesses neutralizing capacity alone. Even though most of the reported anti-HN MAbs possess both activities, MAbs to other paramyxoviruses, with neutralization ability but lacking HI activity, have been described (Oryell, 1984; Orvell & Grandien, 1982) . Thus the difference between the neutralization and HI functions is emphasized (Dimmock, 1984) .
The lack of cross-reactivity of the PIV2 MAbs with other members of the paramyxovirus genus indicates a distant relationship between these viruses and PIV2. This supports the results of a previous study, in which no reaction of MAbs directed against PIV 1, PIV3 and mumps virus could be demonstrated with PIV2 (Orvell et al., 1986 ). It appears that Sendai virus and PIV3 are closely related and that Sendai virus is also related to mumps virus (Goswami & Russell, 1983, Orvell et al., t 986; Ito et al., 1987 a) . These three viruses have not been shown to cross-react with SV5, PIV2 or NDV. PIV2 and SV5 are, however, related as demonstrated in two studies in which whole serum against PIV2 cross-reacted with SV5 (Goswami & Russell, 1982; Ito et al., 1987a) and in a study where two MAbs against the HN and NP proteins of SV5 cross-reacted with PIV2 (Goswami & Russell, 1983) . The present study has demonstrated that the HN proteins of PIV2 and SV5 may be more different than previous results have indicated; the exact nature of the homology remains to be determined. Finally, the distinct staining capacity of all MAbs in IF demonstrates their potential for use as clinical reagents.
